IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy
Interleukin 1 receptor antagonist (IL-1Ra) is a naturally occurring IL-1 inhibitor, acting as a "receptor antagonist", which blocks IL-1 mediated signal transduction. In 1990 IL-1Ra was cloned and later on, a large numbers of studies led to disclosure of the crucial importance of the imbal...
Saved in:
Main Authors: | L. Cozzi (Author), M. Vezzù (Author), U. Fiocco (Author), S. Todesco (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis
by: S. Todesco, et al.
Published: (2011) -
IL-1Ra: its role in rheumatoid arthritis
by: M. Cutolo
Published: (2011) -
The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
by: G. S. Smith, et al.
Published: (1996) -
High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype
by: S. Ramírez-Pérez, et al.
Published: (2017) -
Selection of excipients for the purpose of creating an intranasal gel of interleukin-1 receptor antagonist β (IL-1ra)
by: B. S. Burlaka, et al.
Published: (2020)